{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:19:54Z","timestamp":1777421994012,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T00:00:00Z","timestamp":1463184000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00403-016-1654-7","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T17:16:44Z","timestamp":1463246204000},"page":"423-427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["TOX expression in cutaneous B-cell lymphomas"],"prefix":"10.1007","volume":"308","author":[{"given":"Anne M. R.","family":"Schrader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patty M.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rein","family":"Willemze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,14]]},"reference":[{"issue":"1","key":"1654_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20071944","volume":"205","author":"P Aliahmad","year":"2008","unstructured":"Aliahmad P, Kaye J (2008) Development of all CD4 T lineages requires nuclear factor TOX. J Exp Med 205(1):245\u2013256","journal-title":"J Exp Med"},{"issue":"10","key":"1654_CR2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/ni.1930","volume":"11","author":"P Aliahmad","year":"2010","unstructured":"Aliahmad P, de la Torre B, Kaye J (2010) Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat Immunol 11(10):945\u2013952","journal-title":"Nat Immunol"},{"issue":"6769","key":"1654_CR3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769):503\u2013511","journal-title":"Nature"},{"issue":"9","key":"1654_CR4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/cup.12490","volume":"42","author":"SE Boonk","year":"2015","unstructured":"Boonk SE, Cetinozman F, Vermeer MH, Jansen PM, Willemze R (2015) Differential expression of TOX by skin-infiltrating T cells in Sezary syndrome and erythrodermic dermatitis. J Cutan Pathol 42(9):604\u2013609","journal-title":"J Cutan Pathol"},{"issue":"17","key":"1654_CR5","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1158\/1078-0432.CCR-14-2116","volume":"21","author":"E Braggio","year":"2015","unstructured":"Braggio E, Van Wier S, Ojha J, McPhail E, Asmann YW, Egan J, da Silva JA, Schiff D, Lopes MB, Decker PA et al (2015) Genome-wide analysis uncovers novel recurrent alterations in primary central nervous system lymphomas. Clin Cancer Res 21(17):3986\u20133994","journal-title":"Clin Cancer Res"},{"issue":"19","key":"1654_CR6","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1158\/1078-0432.CCR-12-0845","volume":"18","author":"A Gonzalez-Aguilar","year":"2012","unstructured":"Gonzalez-Aguilar A, Idbaih A, Boisselier B, Habbita N, Rossetto M, Laurenge A, Bruno A, Jouvet A, Polivka M, Adam C et al (2012) Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas. Clin Cancer Res 18(19):5203\u20135211","journal-title":"Clin Cancer Res"},{"issue":"12","key":"1654_CR7","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.18632\/oncotarget.2031","volume":"5","author":"Y Huang","year":"2014","unstructured":"Huang Y, Litvinov IV, Wang Y, Su MW, Tu P, Jiang X, Kupper TS, Dutz JP, Sasseville D, Zhou Y (2014) Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis. Oncotarget 5(12):4418\u20134425","journal-title":"Oncotarget"},{"issue":"9","key":"1654_CR8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00403-014-1501-7","volume":"306","author":"S Morimura","year":"2014","unstructured":"Morimura S, Sugaya M, Suga H, Miyagaki T, Ohmatsu H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S (2014) TOX expression in different subtypes of cutaneous lymphoma. Arch Dermatol Res 306(9):843\u2013849","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"1654_CR9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2164-4-13","volume":"4","author":"E O\u2019Flaherty","year":"2003","unstructured":"O\u2019Flaherty E, Kaye J (2003) TOX defines a conserved subfamily of HMG-box proteins. BMC Genom 4(1):13","journal-title":"BMC Genom"},{"issue":"1","key":"1654_CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3324\/haematol.2014.112912","volume":"100","author":"S Safavi","year":"2015","unstructured":"Safavi S, Hansson M, Karlsson K, Biloglav A, Johansson B, Paulsson K (2015) Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia. Haematologica 100(1):55\u201361","journal-title":"Haematologica"},{"key":"1654_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14508","author":"AM Schrader","year":"2016","unstructured":"Schrader AM, Jansen PM, Willemze R (2016) TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour-specific and not restricted to the CD4+CD8+ phenotype. Br J Dermatol. doi: 10.1111\/bjd.14508","journal-title":"Br J Dermatol"},{"issue":"12","key":"1654_CR12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","volume":"25","author":"NJ Senff","year":"2007","unstructured":"Senff NJ, Hoefnagel JJ, Jansen PM, Vermeer MH, van Baarlen J, Blokx WA, Canninga-van Dijk MR, Geerts ML, Hebeda KM, Kluin PM et al (2007) Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 25(12):1581\u20131587","journal-title":"J Clin Oncol"},{"issue":"3","key":"1654_CR13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ni767","volume":"3","author":"B Wilkinson","year":"2002","unstructured":"Wilkinson B, Chen JY, Han P, Rufner KM, Goularte OD, Kaye J (2002) TOX: an HMG box protein implicated in the regulation of thymocyte selection. Nat Immunol 3(3):272\u2013280","journal-title":"Nat Immunol"},{"issue":"10","key":"1654_CR14","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM et al (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105(10):3768\u20133785","journal-title":"Blood"},{"issue":"3","key":"1654_CR15","doi-asserted-by":"crossref","first-page":"e0117479","DOI":"10.1371\/journal.pone.0117479","volume":"10","author":"X Yu","year":"2015","unstructured":"Yu X, Luo Y, Liu J, Liu Y, Sun Q (2015) TOX acts an oncological role in mycosis fungoides. PLoS One 10(3):e0117479","journal-title":"PLoS One"},{"issue":"6","key":"1654_CR16","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/jid.2012.13","volume":"132","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Wang Y, Yu R, Huang Y, Su M, Xiao C, Martinka M, Dutz JP, Zhang X, Zheng Z et al (2012) Molecular markers of early-stage mycosis fungoides. J Invest Dermatol 132(6):1698\u20131706","journal-title":"J Invest Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-016-1654-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-016-1654-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-016-1654-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:17:20Z","timestamp":1553627840000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-016-1654-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,14]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1654"],"URL":"https:\/\/doi.org\/10.1007\/s00403-016-1654-7","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,14]]}}}